SEC Form 4 · accession 0001209191-19-015553
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sushma Shivaswamy
Officer — Chief Scientific Officer
Period of report
Feb 7, 2019
Accepted (ET)
Mar 4, 2019 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2019 | M | 4,500 | $2.50 | A | 4,500 | D | |
| Common Stock | Feb 7, 2019 | S | 4,500 | $10.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options | $2.50 | Mar 7, 2019 | M | 4,500 | D | May 26, 2010 | May 26, 2019 | Common Stocks | 4,500 | 0 | D |
Remarks
As reflected in this Form 4, the Reporting Person exercised and sold 4,500 stock options on the open market due to the stock options expiring on May 26, 2019.